New updated COVID-19 Boosters now available in Rhode Island

A hand holding a bottle of booster dose with the words coronavirus.

Updated COVID-19 Booster Doses to be Available in Rhode Island Bivalent boosters to target two strains of COVID-19 With a new, more comprehensive COVID-19 booster dose now authorized and recommended by federal health officials, these updated booster shots will start to become available in Rhode Island this week and next. “This is a good reminder…

Read More

Moderna and Pfizer COVID vaccine for children 6 months+ gets FDA approval

RINewsToday

Today, the U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age.  CVS has announced it will provide vaccines for children 18 months and older – otherwise parents can access their…

Read More

NEW: Moderna announces new booster that is Omicron variant specific

RINewsToday

Moderna announces new booster that is Omicron variant specific Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern. A 50 µg booster dose of mRNA-1273.214 met…

Read More

Moving ahead with COVID vaccines for young children

A young boy is being examined by a doctor with a stethoscope.

Moderna (6 mos-5 yrs) and Pfizer (5-11 yrs booster) are next up seeking approval as vaccines. The Moderna will be 2 shots, 4 weeks apart, at 25% strength of an adult shot for children 6 mos to 5 years. Pfizer’s approval request is for a booster for children 5 to 11. After the age of…

Read More

Moderna joins Pfizer in recommending 4th vaccine, but expands to all adults, 18+

RINewsToday

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and…

Read More

Moderna, Johnson & Johnson Boosters available now – Mix & Match OK

RINewsToday

Moderna, Johnson & Johnson COVID-19 Vaccine Boosters Now Available; Recommendations Allow Individuals to Choose Type of Vaccine for Booster Dose Governor Dan McKee and the Rhode Island Department of Health announced today that Moderna and Johnson & Johnson (Janssen) COVID-19 vaccine boosters are now available and recommended as follows: Moderna A single booster dose of…

Read More

NEW: CDC recommends immunocompromised get additional vaccine 28 days after 2nd vaccine

RINewsToday

COVID-19 Vaccines for Moderately to Severely Immunocompromised People What You Need to Know People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised…

Read More

Vaccinating children, as young as 6 months, may be focus by the fall

RINewsToday

Moderna’s CEO said at a professional conference yesterday that he predicted that its COVID-19 vaccine will likely be available for children as young as five by the early fall. “I think it’s going to be early fall, just because we have to go down in age very slowly and carefully,” the Cambridge-based company’s CEO Stéphane…

Read More

Moderna begins study of vaccine in children, 6 mos-12 yrs

RINewsToday

Enrolling 6,750 healthy pediatric participants less than 12 years of age in the U.S. and Canada Moderna Inc., a biotechnology company pioneering messenger RNA(mRNA) therapeutics and vaccines, today announced that the first participants have been dosed in the Phase 2/3 study, called the KidCOVE study, ofmRNA-1273, the Company’s vaccine candidate against COVID-19, in children ages…

Read More